GlassScriptPhysician profile
Lisa M Hall
NPI 1114945953
$6,883.15
in general payments reported to CMS, 2019-2025
46 companies · $1,471 in 2025
The $1,471 reported for 2025 was more than what 89% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,257 · 2022: $1,413 · 2023: $1,367 · 2024: $1,375 · 2025: $1,471.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,213.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,213.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,214.93 | 2021-2025 | |
| Novo Nordisk INC | $1,049.36 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Janssen Biotech, INC. | $479.37 | 2023-2025 | Tremfya, Stelara, Simponi |
| Gilead Sciences, INC. | $299.56 | 2023-2025 | Epclusa |
| Ardelyx, INC. | $275.09 | 2023-2025 | Ibsrela |
| Astrazeneca Pharmaceuticals LP | $274.02 | 2021-2023 | Farxiga |
| Pfizer INC. | $272.13 | 2021-2025 | |
| Lilly USA, LLC | $245.66 | 2021-2025 | Omvoh, Jardiance, Mounjaro |
| Regeneron Healthcare Solutions, INC. | $228.43 | 2023-2025 | Dupixent |
| Celgene Corporation | $195.36 | 2023-2024 | Zeposia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $162.45 | 2021-2025 | Xifaxan, Plenvu, Trulance |
| Takeda Pharmaceuticals U.S.A., INC. | $153.89 | 2023-2025 | Entyvio, Eohilia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $146.61 | 2021-2024 | Cyltezo, Stiolto Respimat |
| Amarin Pharma, INC. | $142.96 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $139.22 | 2021-2023 | Pneumovax 23, Vaxneuvance, Gardasil 9 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.